Ocular Therapeutix Inc
(NASDAQ : OCUL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-0.31%66.8522.0%$202.67m
ZGNXZogenix, Inc.
1.64%38.7316.8%$131.61m
SHPGShire PLC Sponsored ADR
-3.40%146.880.4%$117.39m
VRXValeant Pharmaceuticals International, Inc.
-3.36%12.3814.2%$102.09m
PRGOPerrigo Co. Plc
-0.55%88.096.5%$92.89m
AERIAerie Pharmaceuticals, Inc.
-0.23%64.458.6%$65.64m
MNKMallinckrodt Plc
-0.25%32.2817.7%$57.08m
CTLTCatalent Inc
1.32%42.102.7%$56.99m
PTLAPortola Pharmaceuticals, Inc.
-0.28%50.367.9%$52.54m
JAZZJazz Pharmaceuticals Plc
-0.14%140.312.2%$51.17m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.02%110.837.6%$49.30m
UTHRUnited Therapeutics Corporation
-0.30%121.4214.4%$46.91m
ENDPEndo International Plc
-0.39%7.618.9%$38.95m
SUPNSupernus Pharmaceuticals, Inc.
0.18%41.136.4%$37.71m
HZNPHorizon Pharma plc
0.44%13.847.6%$36.35m

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its products include dextenza, sustained release travopost, and posterior segment injections. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.